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ABSTRACT
Objective: To describe the clinical aspects of H1N1 among HIV coinfected patients seen at a reference 
center for AIDS treatment in São Paulo, Brazil. Design: Observational and prospective cohort study. 
Methods: Descriptive study of clinical and laboratory investigation of HIV-infected patients with con-
firmed diagnosis of influenza A (H1N1) in 2009. We analyzed patients monitored in CRT/DST/AIDS, 
a specialized service for people living with HIV, located in São Paulo, Brazil. Results: 108 individuals 
presented with symptoms of H1N1 infection at the CRT DST/AIDS in 2009. Eighteen patients (16.7%) 
had confirmation of the diagnosis of influenza A. Among the confirmed cases, ten (55.6%) were hos-
pitalized and eight (44.4%) were outpatients. Dyspnea was present in nine patients (50%), hemoptysis 
in three (16%). Six patients (60%) required therapy with supplemental oxygen. All patients had good 
clinical outcomes and none died. Conclusions: In our hospital, the symptoms that led patients to seek 
medical care were similar to the common flu. Hospital admission and the early introduction of antibi-
otics associated with oseltamivir may have been the cause of the favorable outcome of our cases. 
Keywords: influenza A virus, H1N1 subtype; HIV; acquired immunodeficiency syndrome.
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INTRODUCTION 
In April 2009, a new viral subtype of influenza 
virus was identified in Mexico, United States 
and Canada.1,2 In July 2009 the first cases of sus-
tained transmission of influenza A (H1N1) were 
confirmed in Brazil.1,3 Cases of severe acute res-
piratory syndrome associated with influenza A 
started to be described in all regions of Brazil. 
Many patients presented pulmonary compli-
cations, especially children, pregnant women, 
obese and people with comorbidities, such as 
diabetes, hypertension, cardiovascular disease, 
immunodeficiencies and malignancies.
Sustained transmission of H1N1 virus in 
Brazil had already been declared.1,3 In this new 
epidemic scenario, the Health Ministry in Brazil 
started to give priority to the investigation and 
treatment of patients with severe acute respiratory 
syndrome (SARS) and those who were at risk for 
complications, as patients with chronic diseases.
Initially, even patients with mild symptoms 
were hospitalized, considering the possibility of 
an evolution with greater severity in this group 
of patients. Later, with more data on H1N1 and 
on disease outcome, only cases with more se-
vere symptoms were hospitalized.
Until July 29, 2009, among 543 confirmed 
cases of SARS in Brazil, 56 patients died, which 
corresponds to a lethality rate of 10.3%.3
In São Paulo, by the end of July, there were 
2,078 suspected cases reported, 894 confirmed 
cases and 27 deaths, representing 48.2% of total 
deaths due to H1N1 infection in Brazil.2
It is known that the H1N1 infection in HIV 
patients is potentially more serious,5,6 but de-
spite the increasingly emerging information 
about the pathogenesis and clinical course of 
the infection caused by H1N1, there are still lit-
tle data available on the course of infection in 
HIV patients. Considering the scarcity of data 
in the literature on H1N1 infection in HIV 
patients, we decided to conduct an analysis of 
patients with confirmed influenza A who re-
ceived care in our service. 
Our study aimed to describe the main clini-
cal, laboratory and radiological findings in 
HIV-infected patients with confirmed influen-
za A (H1N1) infection at the Center for Refer-
ence and Training in STD / AIDS of Health Sec-
retariat of São Paulo (CRT DST/AIDS), a highly 
specialized health care center for people living 
with HIV, located in São Paulo city, Brazil.
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METHODOLOGY
A descriptive clinical and laboratorial study was conduct-
ed with all cases with confirmed diagnosis of influenza A 
(H1N1) among HIV-infected individuals attended at CRT/
STD/AIDS. Confirmed cases of influenza A were defined as 
patients with a positive PCR (real-time reverse transcriptase 
polymerase chain reaction assay) for influenza A (H1N1).
The PCR test at nasopharyngeal secretions was collected 
at admission to the service among those with symptoms 
suggestive of influenza, such as high fever, cough, myal-
gia, sore throat and respiratory distress. The samples were 
sent to Adolfo Lutz Institute (ALI), the reference labora-
tory for diagnosis of influenza A (H1N1) in São Paulo, for 
analysis. Data was prospectively collected. A protocol with 
patient information as identification, epidemiological his-
tory of exposure to H1N1, data related to the HIV infec-
tion (including use of antiretroviral and adherence to them, 
history of immunization against seasonal influenza in the 
past year, tobacco use, comorbidities, signs of influenza 
and related symptoms) were collected. Results of radiologi-
cal and laboratory tests of each patient were also included. 
These questionnaires were completed by infectious disease 
specialists who were providing care to patients. We used the 
same instrument for inpatients and outpatients evaluation. 
The questionnaires were reviewed by the principal investiga-
tor and when important data were missing, it was retrieved 
from the medical records.
Body mass index (BMI) of all patients were calculated to 
determine if there was obesity or not. In this study, any patient 
with a BMI greater than 30 kg/m2 was considered obese.
The case definition of pneumonia was the presence 
of acute pulmonary infiltrate associated with the presence of 
one or more of the following signs or symptoms: dyspnea, 
fever, hypoxemia, cough and chest pain.
RESULTS
Our study was conducted from July 22 to October 30, 2009. 
During this period 108 samples of nasopharyngeal swabs 
were tested for H1N1 infection in HIV-infected individuals. 
Eighteen HIV-infected tested positive for H1N1 (first posi-
tive test result at 22nd July 2009. Last positive result at 23rd 
September 2009).
The obtained convenience sample of eighteen patients 
with positive PCR were followed-up. No pregnant patient 
was included in our study.
Among the eighteen confirmed patients with H1N1 
infection, ten (55.6%) were hospitalized and eight (44.4%) 
were treated as outpatients. Thirteen (73%) were male and 
five female (27%). The mean age was 41.3 years (ranging 
from 12 to 59 years) and body mass index (BMI) ranged 
from 16.7 to 31.5 (mean 24). Seventeen patients (94%) were 
on antiretroviral therapy (Table 1).
Table 1. Clinical and laboratorial findings of HIV-
infected patients with confirmed H1N1 infection in 
CRT/DST /AIDS, São Paulo, Brazil
  n = 18 patients 
  (100%)
Gender 
 Male 13 (73%)
 Female 5 (23%)
Use of antiretroviral drugs 
 Yes 17 (94%)
 No 1 (6%)
CD4 count
 > 200 cels/mm3 15 (84%)
 < 200 cels/mm3 3 (16%)
HIV viral load (HIV RNA quantitative)
 < 50 14 (77%)
 > 50 4 (23%)
History of seasonal influenza vaccine
 Yes 9 (50%)
 No 9 (50%)
Comorbidities 
 Obesity 1 (5%)
 Hypertension 5 (27%)
 Diabetes 2 (11%)
 Depression 3 (16%)
 Pulmonary tuberculosis 2 (11%)
 Smoking 2 (11%)
 Asthma 1 (5%)
CD4 count ranged from 271,149 cells/mm3, with an av-
erage of 600 cells/mm3. Only three patients (16%) had CD4 
counts below 200 cells/mm3. HIV viral load was undetect-
able in fourteen patients (77%). The mean length of HIV 
infection was thirteen years. Only nine patients (50%) had 
received seasonal influenza vaccine in the previous year.
For other comorbidities, five (27%) had hypertension, 
two (11%) had diabetes, three (16%) had depression and two 
(11%) had a history of pulmonary tuberculosis. One case (5%) 
had been diagnosed of asthma and two (11%) were smokers.
Regarding symptoms, sixteen patients (88%) had fever 
over 38°C that lasted up to twelve days when they were di-
agnosed with influenza A. Myalgia was present in nine pa-
tients (50%), arthralgia in only one case (5%). Cough was 
reported by all patients (100%). Dyspnea was present in nine 
patients (50%), hemoptysis in three cases (16%). Chest x-
rays were available for sixteen patients. Four patients (25%) 
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had diffuse interstitial infiltrates, one case (6%) showed 
bilateral alveolar infiltrate, one showed an opacity in 
the right base, and ten of sixteen (62.5%) patients had 
normal chest radiology. Hypoxemia (pO2 < 70 mmHg), 
and pneumonia were detected in six patients. Six pa-
tients (33%) required therapy with supplemental oxy-
gen through a Venturi mask and one also needed CPAP. 
There was no need for mechanical ventilation in any 
patient. In the group of ten inpatients, increased LDH 
was found in three patients (30%). Only one patient had 
thrombocytopenia (10%). Three patients had increased 
CPK (30%).
The average hospital stay was 5.3 days. Sixteen pa-
tients (88%) received treatment with oseltamivir for 
five days and in twelve cases (66%) it was necessary to 
combine treatment with antibiotics. No patient received 
treatment with corticosteroids.
DISCUSSION
Considering the scarcity of data in the literature on 
H1N1 infection in HIV patients, we decided to perform 
an analysis of patients with confirmed influenza A in 
our service. A total of 108 samples of nasopharyngeal 
swabs were tested for H1N1 infection, but only eighteen 
turned out positive. In consequence, the number of pa-
tients evaluated was small, and this limitation should be 
borne in mind.
Another study of hospitalized HIV-infected patients 
with H1N1 in the United States showed that most of them 
with immunosuppression and preexisting conditions, 
had developed more severe H1N1 infection.4,6 However, 
in our service, all confirmed cases of influenza A had 
satisfactory outcomes. The vast majority of patients had 
high CD4 (above 500 cells/mm3) and undetectable HIV 
RNA quantitative, which may have contributed to this 
favorable development. However, it is noteworthy that 
even those who had low CD4 progressed well. Antivi-
ral therapy (Oseltamivir 150 mg/day) was initiated early 
on and the majority of patients presented with normal 
chest x-ray, in contrast with other studies that observed 
greater pulmonary involvement.8 Only one patient in 
our study was considered obese.
Associated bacterial infections were common in our 
study, especially pneumonia, otitis and sinusitis with 
negative blood cultures. Many patients had to receive 
both antibiotics and Oseltamivir. Complications ob-
served were: pneumonia (six patients, 33%), sinusitis 
(one patient, 5%), pancreatitis (one case, 5%) and otitis 
(two patients 11%).
In an autopsy study performed in 77 patients with 
death attributed to H1N1 infection, 22 had histopatho-
logical and immunohistochemical evidence of concomi-
tant bacterial lung infection.9
The association between bacterial pneumonia and 
influenza has been well documented through experi-
ence gained in other influenza epidemics.10 These data 
point to the fact that concomitant bacterial infections 
may contribute to mortality in patients with H1N1.
Many of our inpatients were treated with antibiotics ear-
ly on. Two patients who did not receive antibiotics returned 
later with important bacterial complications. One had severe 
pneumonia within thirty days of treatment with Oseltami-
vir, requiring hospitalization, intravenous antibiotic therapy 
and use of supplemental oxygen. Another patient presented 
with otitis media with suppuration few days after initiation 
of treatment for H1N1 with Oseltamivir.
In addition to pneumonia and otitis, sinusitis was 
also found. We believe that in HIV-infected patients, 
antibiotics should be strongly considered because of the 
possibility of unfavorable outcomes in these cases.
One patient tested positive for H1N1 twelve days 
after onset of symptoms. This patient presented with 
more severe symptoms. This finding is consistent with 
the data shown by a study conducted in Mexico that 
evaluated HIV-infected patients with H1N1.This study 
showed that duration of disease was higher in HIV-in-
fected compared to HIV-negative patients.10
Finally, some patients in our study persisted with 
positive H1N1 (RT-PCR) samples even after full treat-
ment with Oseltamivir (five days). This should be val-
ued, since persistence of viral replication after treatment 
with antiviral drugs may be related to the emergence of 
resistant strains. The same finding was described in the 
aforementioned study.10
CONCLUSION
The presence of OIs or bacterial infection suggests a 
more complicated course of the disease and may mask 
the influenza symptoms and signs, resulting in delayed 
treatment with a consequent increased risk for a more 
severe disease and death.
HIV-infected patients should be routinely screened 
for influenza in the context of an outbreak and OIs, and 
should have early antiviral treatment and early indica-
tion of flu vaccine.7,11-13
Admission to the hospital and early introduction of 
antibiotics associated with Oseltamivir may explain the 
favorable outcomes of our cases.
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